Drug Type ASO |
Synonyms DMD Other Exons(Dyne), DMDOther Exons(Dyne) |
Target |
Mechanism TfR1 antagonists(Transferrin receptor protein 1 antagonists), dystrophin modulators(Dystrophin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | US | 25 Jul 2024 |